Bridgeway Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-79,000
| Closed | -$867K | – | 1389 |
|
|
2020
Q1 | $867K | Buy |
79,000
+44,000
| +126% | +$483K | 0.02% | 599 |
|
|
2019
Q4 | $307K | Hold |
35,000
| – | – | ﹤0.01% | 1113 |
|
|
2019
Q3 | $261K | Hold |
35,000
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q2 | $326K | Buy |
+35,000
| New | +$326K | ﹤0.01% | 1079 |
|
|
2018
Q4 | – | Sell |
-101,800
| Closed | -$823K | – | 1449 |
|
|
2018
Q3 | $823K | Buy |
101,800
+51,300
| +102% | +$415K | 0.01% | 979 |
|
|
2018
Q2 | $355K | Hold |
50,500
| – | – | ﹤0.01% | 1218 |
|
|
2018
Q1 | $719K | Hold |
50,500
| – | – | 0.01% | 959 |
|
|
2017
Q4 | $442K | Hold |
50,500
| – | – | ﹤0.01% | 1131 |
|
|
2017
Q3 | $591K | Hold |
50,500
| – | – | 0.01% | 1045 |
|
|
2017
Q2 | $705K | Hold |
50,500
| – | – | 0.01% | 964 |
|
|
2017
Q1 | $693K | Buy |
+50,500
| New | +$693K | 0.01% | 947 |
|